Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

eased from 50% of net profits to 20% of net profits, calculated in accordance with the amendment.

For the quarter ended September 30, 2010, the Company's marketing and selling expenses increased 56%, or $31,000, to $86,000 compared to $55,000 for the same period in 2009. This increase was primarily due to marketing and sales brokerage related expenses associated with the planned distribution of the nutritional products.  

General and administrative expenses decreased 47%, or $571,000, to $650,000 for the three months ended September 30, 2010, compared to $1.2 million for the same period in 2009, primarily due to lower personnel-related expenses through personnel reductions.

Research and development expenses decreased 55%, or $315,000, to $257,000 for the three months ended September 30, 2010, compared to $572,000 for the same period in 2009, primarily due to reductions in personnel and other expenses reflecting the deferral of development activities for certain product candidates.

Net loss decreased 45%, or $716,000, to $869,000 for the three months ended September 30, 2010, compared to $1.6 million for the same period in 2009. The decrease was primarily due to lower overall operating expenses.

As of September 30, 2010, the Company had approximately $2.4 million in cash and cash equivalents, and $275,000 in restricted cash. Based on its current operating plan, the Company anticipates that existing cash and cash equivalents, together with expected royalties from third parties, will be sufficient to fund operations into the second quarter of 2011, unless unforeseen events arise that negatively impact liquidity.

 Nine Months 2010 compared to Nine Months 2009 Financial ResultsTotal revenues decreased 23%, or $151,000, to $513,000 for the nine months ended September 30, 2010, compared to $664,000 for the same period in 2009. This decrease is primarily due to a reduction in royalty revenue from the Company's relati
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... MENLO PARK, Calif. , Sept. 4, ... ("DelMar" and the "Company"), a biopharmaceutical company focused on ... announced its financial results for the fiscal year ending ... Company highlights and expected near-term milestones. ... call and live webcast for investors, analysts and other ...
(Date:9/3/2015)... -- Report Details ... R&D and Sales Potentials ... Visiongain,s new report gives you revenue predictions for that industry ... data, R&D trends, opportunities, interviews and revenue forecasts. ... forecasted sales to 2025 at overall world market, submarket, product ...
(Date:9/3/2015)... , Sept. 3, 2015 ... a condition that involves narrowing or blockage of ... heart rhythm problems, smoking, high cholesterol, and high ... arterial disease, atherosclerosis, and heart failure are some ... obstruction of blood vessels, especially coronary arteries, is ...
Breaking Medicine Technology:DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Cardiovascular Implants Market 2015-2019 2
(Date:9/4/2015)... ... , ... The Schmidt National Law Group filed an Essure® lawsuit against Bayer ... Law Group, a leading firm in mass-tort litigation, has filed a lawsuit in the ... and other Bayer affiliates for injuries alleged to have been caused by her Essure® ...
(Date:9/4/2015)... ... 04, 2015 , ... Inmar announced today that its regulatory ... Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , With the ... goods industry, it can be difficult for companies to navigate, stay abreast of ...
(Date:9/4/2015)... ... 04, 2015 , ... “Getting away from the daily stressors and distractions of ... strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort ... island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference ... in Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has ... are doctors and researchers at the top of their field and will be ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal ... under the Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best ... Information Services, Inc. (AIS), will detail which deals are attracting the most government ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... while Botox may erase wrinkles and restore youthful good looks, ... Carter Singh, who has a degree in psychology and is ... Martin Kelly, of London Plastic Surgery Associates, said in a ... treatments do so repetitively. , ,Reacting to the ...
... Americans of all ages, affecting their quality of life ... for some patients they neither respond to surgery and ... why new devices surgically implanted in the brain itself ... ,Neurologists at the University of Virginia Health System are ...
... heart failure and men with treated prostate cancer are among ... Now, under new guidelines co-authored by a Hopkins cardiologist and ... Transplantation (ISHLT), they can and should be considered. ,“People ... have a chance to get a new heart,” says Stuart ...
... well prepared to make the decision to stop dialysis ... // , reports a study in the November Clinical ... who are more experienced and more familiar with the ... Physicians Association and the American Society of Nephrology (RPA/ASN)—are ...
... in Nieuwegein, the Netherlands say that although people suffering ... more frequently, air swallowing does not play any role ... air swallowing had any role in GERD, researchers calculated ... people with GERD and 12 healthy individuals. GERD ...
... reduce the amount of sugar (glucose) in the blood, could help ... diabetes occurs when people cannot produce enough insulin, or do not ... sugars to be turned into body fuel. ,People ... at high risk of Type 2 diabetes. The disease is mainly ...
Cached Medicine News:Health News:Epilepsy Treated with Implanted Devices 2Health News:Now, Even Older Adults and Some Cancer Patients can go for Heart Transplantation 2Health News:Many Kidney Specialists Feel Unprepared for End-of-Life Decisions 2
... The Polaris system delivers the ... cost effective and easy to use, ... level of precision measurement with unprecedented ... both active and passive tools, the ...
Penfield Dissector #4...
Leroy scalp clips, sterile, disposable, plastic, infant size, ten clips/package....
Disposable scalp clip applier, comes loaded with 12 Leroy-Raney clips, ergonomic, easy to handle and position the clip....
Medicine Products: